Table 2 Univariate and multivariate analysis for cause-specific mortality in patients with type 2 diabetes mellitus
Outcomes | Quartiles of baPWV (cm/s) | Univariate | Multivariate | ||
|---|---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P-value | ||
All-cause mortality | Q1 (–1391) | Reference |  | Reference |  |
Q2 (1392–1593) | 1.09 (0.62–1.92) | 0.760 | 0.89 (0.50–1.59) | 0.703 | |
Q3 (1594–1829) | 1.67 (1.00–2.80) | 0.052 | 1.14 (0.66–1.96) | 0.647 | |
Q4 (1830–) | 5.39 (3.44–8.44) | < 0.001 | 2.55 (1.49–4.35) | 0.001 | |
Cardiovascular-mortality | Q1 (–1391) | Reference |  | Reference |  |
Q2 (1392–1593) | 4.52 (0.98–20.92) | 0.054 | 3.60 (0.77–16.91) | 0.104 | |
Q3 (1594–1829) | 5.56 (1.23–25.08) | 0.026 | 3.36 (0.72–15.73) | 0.123 | |
Q4 (1830–) | 14.89 (3.54–62.61) | < 0.001 | 5.57 (1.19–26.18) | 0.030 | |
Cancer-mortality | Q1 (–1391) | Reference |  | Reference |  |
Q2 (1392–1593) | 1.34 (0.47–3.86) | 0.588 | 1.24 (0.43–3.62) | 0.694 | |
Q3 (1594–1829) | 2.02 (0.76–5.38) | 0.160 | 1.80 (0.65–5.05) | 0.261 | |
Q4 (1830–) | 5.42 (2.25–13.02) | < 0.001 | 4.35 (1.57–12.03) | 0.005 | |
Other cause-mortality | Q1 (–1391) | Reference |  | Reference |  |
Q2 (1392–1593) | 0.54 (0.23–1.26) | 0.154 | 0.41 (0.17–0.99) | 0.046 | |
Q3 (1594–1829) | 1.01 (0.49–2.07) | 0.975 | 0.61 (0.28–1.30) | 0.198 | |
Q4 (1830–) | 4.12 (2.33–7.28) | < 0.001 | 1.59 (0.78–3.26) | 0.207 | |